TRACON intends to initiate a Phase 1 trial of YH001 in combination with envafolimab in soft tissue sarcoma as well as to study YH001 in multiple other selected tumor types YH001 was developed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results